Herpes zoster ophthalmicus

被引：1

作者：

Kovacevic, Jasmina ^{[1
]}

Samia, Arthur Mark ^{[2
]}

Shah, Ankit ^{[3
]}

Motaparthi, Kiran ^{[2
]}

机构：

[1] Univ Florida, Coll Med, Gainesville, FL USA

[2] Univ Florida, Coll Med, Dept Dermatol, Gainesville, FL 32611 USA

[3] Univ Florida, Dept Ophthalmol, Coll Med, Gainesville, FL USA

来源：

CLINICS IN DERMATOLOGY | 2024年 / 42卷 / 04期

关键词：

POSTHERPETIC NEURALGIA; NATURAL-HISTORY; ORAL ACYCLOVIR; SIMPLEX-VIRUS; RISK-FACTORS; MANAGEMENT; EPIDEMIOLOGY; DIAGNOSIS; CULTURE; PCR;

D O I：

10.1016/j.clindermatol.2024.01.007

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Herpes zoster ophthalmicus (HZO) occurs when latent varicella zoster virus reactivates in the ophthalmic division of the fifth cranial nerve (CNV1). HZO commonly affects older and immunocompromised patients. This disease is considered an ophthalmic emergency due to the wide range of associated ocular symptoms, including severe chronic pain and vision loss. HZO is typically a clinical diagnosis due to its classic presentation of a unilateral vesicular eruption in the dermatomes corresponding to CNV1. Timely treatment is imperative to minimize ocular morbidity in HZO, given that ocular involvement is present in 50% of affected patients. (c) 2024 Elsevier Inc. All rights reserved.

引用

页码：355 / 359

页数：5

共 48 条

[1] Diagnosis and management of herpes zoster ophthalmicus [J].

Anderson, Erik ;

Fantus, Robert J. ;

Haddadin, Ramez I. .

DM DISEASE-A-MONTH, 2017, 63 (02) :38-44

[2]

[Anonymous], 2015, Epidemiology and prevention of vaccine-preventable diseases

[3] Viral anterior uveitis [J].

Babu, Kalpana ;

Konana, Vinaya Kumar ;

Ganesh, Sudha K. ;

Patnaik, Gazal ;

Chan, Nicole S. W. ;

Chee, Soon-Phaik ;

Sobolewska, Bianka ;

Zierhut, Manfred .

INDIAN JOURNAL OF OPHTHALMOLOGY, 2020, 68 (09) :1764-1773

[4]

Catron T, 2008, WEST J EMERG MED, V9, P174

[5] Comparison of chemicon SimulFluor direct fluorescent antibody staining with cell culture and shell vial direct immunoperoxidase staining for detection of herpes simplex virus and with cytospin direct immunofluorescence staining for detection of varicella-zoster virus [J].

Chan, EL ;

Brandt, K ;

Horsman, GB .

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2001, 8 (05) :909-912

[6] Risk factors for postherpetic neuralgia [J].

Choo, PW ;

Galil, K ;

Donahue, JG ;

Walker, AM ;

Spiegelman, D ;

Platt, R .

ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (11) :1217-1224

[7] Recent advances in varicella-zoster virus infection [J].

Cohen, JI ;

Brunell, PA ;

Straus, SE ;

Krause, PR .

ANNALS OF INTERNAL MEDICINE, 1999, 130 (11) :922-932

[8]

Cukic Vesna, 2016, Med Arch, V70, P72, DOI 10.5455/medarh.2016.70.72-75

[9] Recommendations for the management of herpes zoster [J].

Dworkin, Robert H. ;

Johnson, Robert W. ;

Breuer, Judith ;

Gnann, John W. ;

Levin, Myron J. ;

Backonja, Miroslav ;

Betts, Robert F. ;

Gershon, Anne A. ;

Haanpaa, Maija L. ;

McKendrick, Michael W. ;

Nurmikko, Turo J. ;

Oaklander, Anne Louise ;

Oxman, Michael N. ;

Pavan-Langston, Deborah ;

Petersen, Karin L. ;

Rowbotham, Michael C. ;

Schmader, Kenneth E. ;

Stacey, Brett R. ;

Tyring, Stephen K. ;

van Wijck, Albert J. M. ;

Wallace, Mark S. ;

Wassilew, Sawko W. ;

Whitley, Richard J. .

CLINICAL INFECTIOUS DISEASES, 2007, 44 :S1-S26

[10] Varicella zoster virus infection [J].

Gershon, Anne A. ;

Breuer, Judith ;

Cohen, Jeffrey I. ;

Cohrs, Randall J. ;

Gershon, Michael D. ;

Gilden, Don ;

Grose, Charles ;

Hambleton, Sophie ;

Kennedy, Peter G. E. ;

Oxman, Michael N. ;

Seward, Jane F. ;

Yamanishi, Koichi .

NATURE REVIEWS DISEASE PRIMERS, 2015, 1

← 1 2 3 4 5 →